Variant NM_000492.4:c.1624G>T
Name | NM_000492.4:c.1624G>T |
Protein name | NP_000483.3:p.(Gly542*) |
Genomic name (hg19) | chr7:g.117227832G>T UCSC |
#Exon/intron | exon 12 |
Legacy Name | G542X |
Class | disease-causing |
Subclass | CF-causing |
WT sequence | TGCAGAGAAAGACAATATAGTTCTT G GAGAAGGTGGAATCACACTGAGTGG |
Mutant sequence | TGCAGAGAAAGACAATATAGTTCTT T GAGAAGGTGGAATCACACTGAGTGG |
dbSNP rs113993959 |
Not found |
3 individuals carrying this variant are reported in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 232 |
---|---|
Asymptomatic compound heterozygote | 2 |
CF | 165 |
CFTR-RD | 47
|
Fetal bowel anomalies | 4 |
Pending | 2 |
Pending (NBS) | 12 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CF | 3328 | heterozygote | CF-causing - Trans |
CF | 2865 | heterozygote | CF-causing - Trans |
CF | 2844 | heterozygote | CF-causing - Trans |
CF | 2826 | heterozygote | CF-causing - Trans |
CF | 2804 | heterozygote | CF-causing - Trans |
CF | 2802 | heterozygote | CF-causing- Undef |
CF | 2779 | heterozygote | CF-causing- Undef |
CF | 2778 | heterozygote | CF-causing- Undef |
CF | 2769 | heterozygote | CF-causing - Trans |
CF | 3190 | heterozygote | CF-causing - Trans |
CF | 3168 | heterozygote | varying clinical consequence - Trans |
CF | 3124 | heterozygote | CF-causing- Undef |
CF | 3099 | heterozygote | varying clinical consequence - Trans |
CF | 3071 | heterozygote | CF-causing - Trans |
CF | 3027 | heterozygote | CF-causing - Trans |
CF | 3004 | heterozygote | CF-causing - Trans |
CF | 2977 | heterozygote | CF-causing - Trans |
CF | 2973 | heterozygote | CF-causing - Trans |
CF | 2955 | heterozygote | CF-causing - Trans |
CF | 2763 | heterozygote | CF-causing - Trans |
CF | 2691 | heterozygote | varying clinical consequence - Trans |
CF | 2197 | heterozygote | varying clinical consequence- Undef |
CF | 2176 | heterozygote | CF-causing- Undef |
CF | 2124 | heterozygote | CF-causing- Undef |
CF | 2097 | heterozygote | CF-causing- Undef |
CF | 2062 | heterozygote | CF-causing- Undef |
CF | 2059 | heterozygote | varying clinical consequence- Undef |
CF | 2042 | heterozygote | CF-causing- Undef |
CF | 2035 | heterozygote | CF-causing- Undef |
CF | 1997 | heterozygote | CF-causing- Undef |
CF | 1955 | heterozygote | CF-causing- Undef |
CF | 2205 | heterozygote | CF-causing- Undef |
CF | 2216 | heterozygote | CF-causing- Undef |
CF | 2687 | heterozygote | CF-causing - Trans |
CF | 2606 | heterozygote | CF-causing- Undef |
CF | 4912 | heterozygote | varying clinical consequence - Trans |
CF | 2561 | heterozygote | CF-causing- Undef |
CF | 2537 | heterozygote | CF-causing- Undef |
CF | 2534 | heterozygote | CF-causing- Undef |
CF | 2517 | heterozygote | CF-causing- Undef |
CF | 2458 | heterozygote | CF-causing- Undef |
CF | 2274 | heterozygote | CF-causing - Trans |
CF | 2269 | heterozygote | CF-causing- Undef |
CF | 1929 | heterozygote | CF-causing- Undef |
CF | 4368 | heterozygote | CF-causing - Trans |
CF | 4357 | heterozygote | CF-causing- Undef |
CF | 4284 | heterozygote | CF-causing - Trans |
CF | 4186 | heterozygote | CF-causing- Undef |
CF | 4157 | heterozygote | CF-causing- Undef |
CF | 4108 | heterozygote | CF-causing- Undef |
CF | 4098 | heterozygote | CF-causing- Undef |
CF | 4396 | heterozygote | CF-causing- Undef |
CF | 4486 | heterozygote | varying clinical consequence - Trans |
CF | 6041 | heterozygote | VUS3 - Trans |
CF | 4545 | heterozygote | CF-causing - Trans |
CF | 4518 | heterozygote | varying clinical consequence - Trans |
CF | 4514 | heterozygote | CF-causing - Trans |
CF | 4489 | heterozygote | varying clinical consequence - Trans |
CF | 4080 | heterozygote | CF-causing- Undef |
CF | 4051 | heterozygote | CF-causing - Trans |
CF | 4047 | heterozygote | CF-causing- Undef |
CF | 3682 | heterozygote | CF-causing- Undef |
CF | 3664 | heterozygote | CF-causing- Undef |
CF | 3621 | heterozygote | CF-causing- Undef |
CF | 3620 | heterozygote | CF-causing- Undef |
CF | 3526 | heterozygote | CF-causing- Undef |
CF | 3490 | heterozygote | CF-causing- Undef |
CF | 5971 | heterozygote | VUS3 - Trans |
CF | 3419 | heterozygote | CF-causing - Trans |
CF | 3407 | heterozygote | CF-causing - Trans |
CF | 3688 | heterozygote | CF-causing- Undef |
CF | 3764 | heterozygote | CF-causing- Undef |
CF | 4005 | heterozygote | CF-causing- Undef |
CF | 4003 | heterozygote | CF-causing - Trans |
CF | 3990 | heterozygote | CF-causing - Trans |
CF | 3988 | heterozygote | CF-causing - Trans |
CF | 3966 | heterozygote | CF-causing- Undef |
CF | 3930 | heterozygote | CF-causing- Undef |
CF | 3915 | heterozygote | CF-causing- Undef |
CF | 3830 | heterozygote | CF-causing- Undef |
CF | 3824 | heterozygote | CF-causing - Trans |
CF | 3798 | heterozygote | CF-causing - Trans |
CF | 3778 | heterozygote | CF-causing - Trans |
CF | 3777 | heterozygote | CF-causing- Undef |
CF | 883 | heterozygote | CF-causing - Trans |
CF | 588 | heterozygote | CF-causing - Trans |
CF | 471 | heterozygote | varying clinical consequence- Undef |
CF | 390 | heterozygote | CF-causing - Trans |
CF | 594 | heterozygote | varying clinical consequence- Undef |
CF | 596 | heterozygote | CF-causing- Undef |
CF | 860 | heterozygote | CF-causing - Trans VUS3 - Trans |
CF | 802 | heterozygote | varying clinical consequence- Undef |
CF | 798 | heterozygote | varying clinical consequence - Trans |
CF | 788 | heterozygote | varying clinical consequence- Undef |
CF | 732 | heterozygote | CF-causing - Trans |
CF | 731 | heterozygote | CF-causing - Trans |
CF | 702 | heterozygote | CF-causing - Trans |
CF | 671 | heterozygote | CF-causing- Undef |
CF | 597 | heterozygote | CF-causing- Undef |
CF | 356 | heterozygote | CF-causing - Trans |
CF | 346 | heterozygote | CF-causing - Trans |
CF | 341 | heterozygote | CF-causing- Undef |
CF | 143 | heterozygote | CF-causing - Trans |
CF | 119 | heterozygote | CF-causing - Trans |
CF | 110 | heterozygote | CF-causing - Trans |
CF | 99 | heterozygote | CF-causing - Trans |
CF | 97 | heterozygote | CF-causing - Trans |
CF | 47 | heterozygote | CF-causing - Trans VUS3- Undef |
CF | 182 | heterozygote | CF-causing - Trans |
CF | 188 | heterozygote | likely CF - Trans |
CF | 335 | heterozygote | CF-causing- Undef |
CF | 306 | heterozygote | CF-causing - Trans |
CF | 297 | heterozygote | CF-causing - Trans VUS3 - Trans |
CF | 274 | heterozygote | CF-causing - Trans |
CF | 263 | heterozygote | varying clinical consequence - Trans |
CF | 261 | heterozygote | CF-causing- Undef |
CF | 259 | heterozygote | CF-causing- Undef |
CF | 244 | heterozygote | CF-causing - Trans |
CF | 239 | heterozygote | CF-causing - Trans |
CF | 236 | heterozygote | CF-causing- Undef |
CF | 207 | heterozygote | varying clinical consequence - Trans |
CF | 193 | heterozygote | CF-causing - Trans |
CF | 1 | heterozygote | CF-causing - Trans |
CF | 1262 | heterozygote | CF-causing - Trans |
CF | 1203 | heterozygote | CF-causing - Trans |
CF | 1160 | heterozygote | CF-causing - Trans |
CF | 1150 | heterozygote | CF-causing - Trans |
CF | 1146 | heterozygote | CF-causing - Trans |
CF | 1131 | heterozygote | CF-causing - Trans |
CF | 1700 | heterozygote | CF-causing- Undef |
CF | 1130 | heterozygote | |
CF | 1119 | heterozygote | CF-causing- Undef |
CF | 1317 | heterozygote | varying clinical consequence - Trans |
CF | 1852 | heterozygote | CF-causing- Undef |
CF | 1768 | heterozygote | varying clinical consequence- Undef |
CF | 1760 | heterozygote | CF-causing- Undef |
CF | 1714 | heterozygote | CF-causing- Undef |
CF | 1685 | heterozygote | CF-causing- Undef |
CF | 1684 | heterozygote | CF-causing- Undef |
CF | 1525 | heterozygote | CF-causing - Trans |
CF | 1095 | heterozygote | CF-causing - Trans |
CF | 4822 | heterozygote | CF-causing - Trans |
CF | 1004 | heterozygote | CF-causing - Trans |
CF | 1000 | heterozygote | CF-causing - Trans |
CF | 975 | heterozygote | VUS3- Undef |
CF | 973 | heterozygote | CF-causing- Undef |
CF | 968 | heterozygote | CF-causing - Trans |
CF | 936 | heterozygote | CF-causing - Trans |
CF | 909 | heterozygote | varying clinical consequence - Trans |
CF | 4823 | heterozygote | CF-causing - Trans |
CF | 1012 | heterozygote | CF-causing - Trans |
CF | 1094 | heterozygote | CF-causing- Undef |
CF | 1201 | heterozygote | CF-causing - Trans |
CF | 1050 | heterozygote | CF-causing- Undef |
CF | 1045 | heterozygote | CF-causing - Trans |
CF | 889 | heterozygote | CF-causing - Trans |
CF | 5132 | heterozygote | varying clinical consequence - Trans |
CF | 5263 | heterozygote | varying clinical consequence - Trans |
CF | 2229 | homozygote | c.1624G>T - p.(Gly542*) - Trans |
CF | 4796 | homozygote | c.*133T>A - p.(=) - Trans c.1624G>T - p.(Gly542*) - Trans c.54-589A>G - p.(=) - Trans c.870-1113_870-1110del - p.(=) - Trans |
CF | 4193 | homozygote | c.1624G>T - p.(Gly542*) - Trans |
CF | 4130 | homozygote | c.1624G>T - p.(Gly542*) - Trans |
CF | 2670 | homozygote | c.1624G>T - p.(Gly542*) - Trans |
CF | 705 | homozygote | c.1624G>T - p.(Gly542*) - Trans |
CF | 1639 | homozygote | c.1624G>T - p.(Gly542*) - Trans |
Pending (NBS) | 2940 | heterozygote | |
Pending (NBS) | 4920 | heterozygote | varying clinical consequence - Trans |
Pending (NBS) | 5236 | heterozygote | CFTR-RD-causing - Trans |
Pending (NBS) | 4803 | heterozygote | |
Pending (NBS) | 6010 | heterozygote | |
Pending (NBS) | 6033 | heterozygote | varying clinical consequence- Undef |
Pending (NBS) | 5349 | heterozygote | varying clinical consequence- Undef |
Pending (NBS) | 52 | heterozygote | CFTR-RD-causing - Trans |
Pending (NBS) | 1114 | heterozygote | varying clinical consequence - Trans |
Pending (NBS) | 934 | heterozygote | varying clinical consequence - Trans |
Pending (NBS) | 5820 | heterozygote | CFTR-RD-causing - Trans VUS3- Undef |
Pending (NBS) | 5533 | heterozygote | VUS3- Undef |
Pending | 53 | heterozygote | |
Pending | 907 | heterozygote | VUS3 - Trans |
Pancreatitis | 4687 | heterozygote | varying clinical consequence- Undef |
Pancreatitis | 70 | heterozygote | varying clinical consequence - Trans |
Pancreatitis | 5708 | heterozygote | CFTR-RD-causing- Undef |
Pancreatitis | 1225 | heterozygote | |
Other | 4762 | heterozygote | VUS3- Undef |
Other | 2934 | heterozygote | |
Other | 4813 | heterozygote | varying clinical consequence- Undef |
Other | 4801 | heterozygote | CFTR-RD-causing- Undef |
Other | 4317 | heterozygote | |
Other | 6116 | heterozygote | CF-causing- Undef |
Other | 4547 | heterozygote | varying clinical consequence - Trans |
Other | 547 | heterozygote | CFTR-RD-causing - Trans |
Other | 4715 | heterozygote | CFTR-RD-causing - Trans |
Other | 980 | heterozygote | CFTR-RD-causing - Trans varying clinical consequence - Trans |
CBAVD | 4651 | heterozygote | VUS3- Undef VUS1- Undef |
CBAVD | 2822 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 2820 | heterozygote | likely CFTR-RD- Undef |
CBAVD | 3279 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 2730 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 2165 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1968 | heterozygote | varying clinical consequence- Undef |
CBAVD | 4562 | heterozygote | varying clinical consequence - Trans |
CBAVD | 4534 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 5765 | heterozygote | varying clinical consequence- Undef |
CBAVD | 3416 | heterozygote | varying clinical consequence- Undef |
CBAVD | 3376 | heterozygote | varying clinical consequence - Trans |
CBAVD | 589 | heterozygote | varying clinical consequence- Undef |
CBAVD | 553 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 541 | heterozygote | varying clinical consequence - Trans |
CBAVD | 534 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 497 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 483 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 430 | heterozygote | CFTR-RD-causing - Trans CFTR-RD-causing - Trans |
CBAVD | 875 | heterozygote | likely CFTR-RD- Undef |
CBAVD | 679 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 678 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 4740 | heterozygote | VUS1- Undef |
CBAVD | 1250 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1746 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1425 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 1329 | heterozygote | varying clinical consequence- Undef |
CBAVD | 1066 | heterozygote | varying clinical consequence- Undef |
Fetal bowel anomalies | 367 | heterozygote | CF-causing - Trans |
Fetal bowel anomalies | 1286 | heterozygote | CF-causing - Trans |
Fetal bowel anomalies | 2487 | heterozygote | CF-causing- Undef |
Fetal bowel anomalies | 4324 | heterozygote | CF-causing - Trans |
Asymptomatic compound heterozygote | 885 | heterozygote | |
Asymptomatic compound heterozygote | 4961 | heterozygote | CFTR-RD-causing- Undef |
CRS-NP | 910 | heterozygote | |
CRS-NP | 3078 | heterozygote | VUS3 - Trans |
Bronchiectasis | 4601 | heterozygote | CFTR-RD-causing - Trans |
Bronchiectasis | 4866 | heterozygote | CFTR-RD-causing- Undef |
Bronchiectasis | 1792 | heterozygote |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|